AUS
NZ
UK
CA
USA
IND
Highlights
- Ilika makes strides with Stereax battery for medical devices.
- Goliath battery reaches key milestones for electric vehicles.
- Financial results show steady progress, with future revenue growth expected.
The battery technology sector has seen notable advancements in recent years, with companies like Ilika PLC leading the charge in providing innovative solutions. Ilika, a company focused on advanced solid-state batteries, is at the forefront of developing groundbreaking technologies aimed at the medical device and electric vehicle (EV) markets. Its two major product lines, Stereax and Goliath, highlight the company's dedication to enhancing battery performance and addressing the unique needs of these rapidly growing industries.
Stereax Battery for Medical Devices
Ilika's Stereax battery line (OTC:ILIKF) targets the medical device sector, specifically implantable devices. The company has worked in close collaboration with Cirtec Medical to set up production equipment for Stereax at a US-based facility in Massachusetts. This strategic partnership allows Ilika to scale production while ensuring the high standards required for medical device applications. Stereax is expected to begin generating revenue in the upcoming year, as the production setup nears completion.
The company has made significant progress with the installation of equipment in Cirtec’s cleanroom. Following this, attention will shift to commissioning, trial batches, and preparing for commercial sample production in 2025. This marks an important phase for the company as it moves closer to introducing its advanced technology to the medical sector, where there is growing demand for efficient, long-lasting power sources in implantable devices.
Goliath Battery for Electric Vehicles
Ilika’s Goliath battery line focuses on the EV sector, with a goal to improve safety, reduce costs, and extend the driving range of electric vehicles. A significant milestone for the Goliath line came in the form of a fivefold increase in energy capacity compared to earlier prototypes. This achievement demonstrates Ilika’s ability to innovate and meet the increasing energy demands of electric vehicles.
Ilika has also been testing its first prototype batteries with customers, ensuring that they meet the high-performance requirements of the industry. The company has shipped a batch of these prototypes to a Tier 1 partner and validated improvements in safety over traditional EV batteries. These advancements are crucial as the electric vehicle market seeks safer, more cost-effective, and efficient energy solutions. Additionally, the company delivered a 10Ah prototype, pushing Goliath’s development further toward the final product.
Financial Progress and Future Outlook
Ilika's financial results reflect continued growth and commitment to its technological advancements. For the six months ending October 31, the company reported revenue of £1 million, with £900,000 attributed to grants. Cash reserves stood at £10.1 million following a £2.3 million fundraising effort. While the company reported losses of £1.9 million, this remains steady as Ilika focuses on its strategic growth.
Looking ahead, Ilika aims to expand its Stereax production and drive further commercial interest in both the Stereax and Goliath lines. With revenues from Stereax expected in 2025 and the continued development of Goliath prototypes, Ilika is positioning itself to play a significant role in the evolving battery technology sector, particularly as demand for innovative solutions in medical devices and electric vehicles continues to rise.
